- Home
- DLNG vs TCRX Comparison
DLNG vs TCRX Comparison
Compare DLNG & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLNG
- TCRX
- Stock Information
- Founded
- DLNG 2013
- TCRX 2018
- Country
- DLNG Greece
- TCRX United States
- Employees
- DLNG N/A
- TCRX N/A
- Industry
- DLNG Marine Transportation
- TCRX Biotechnology: Pharmaceutical Preparations
- Sector
- DLNG Consumer Discretionary
- TCRX Health Care
- Exchange
- DLNG Nasdaq
- TCRX Nasdaq
- Market Cap
- DLNG 127.5M
- TCRX 140.7M
- IPO Year
- DLNG 2013
- TCRX 2021
- Fundamental
- Price
- DLNG $3.54
- TCRX $1.86
- Analyst Decision
- DLNG
- TCRX Strong Buy
- Analyst Count
- DLNG 0
- TCRX 5
- Target Price
- DLNG N/A
- TCRX $9.40
- AVG Volume (30 Days)
- DLNG 49.8K
- TCRX 656.4K
- Earning Date
- DLNG 11-21-2025
- TCRX 11-07-2025
- Dividend Yield
- DLNG 5.54%
- TCRX N/A
- EPS Growth
- DLNG 90.14
- TCRX N/A
- EPS
- DLNG 1.14
- TCRX N/A
- Revenue
- DLNG $158,453,000.00
- TCRX $6,961,000.00
- Revenue This Year
- DLNG N/A
- TCRX $255.18
- Revenue Next Year
- DLNG $0.37
- TCRX N/A
- P/E Ratio
- DLNG $3.11
- TCRX N/A
- Revenue Growth
- DLNG N/A
- TCRX N/A
- 52 Week Low
- DLNG $3.18
- TCRX $1.02
- 52 Week High
- DLNG $5.65
- TCRX $6.23
- Technical
- Relative Strength Index (RSI)
- DLNG 47.08
- TCRX 39.56
- Support Level
- DLNG $3.45
- TCRX $2.23
- Resistance Level
- DLNG $3.70
- TCRX $2.43
- Average True Range (ATR)
- DLNG 0.11
- TCRX 0.19
- MACD
- DLNG 0.01
- TCRX -0.06
- Stochastic Oscillator
- DLNG 36.00
- TCRX 14.46
About DLNG Dynagas LNG Partners LP Common Units
Dynagas LNG Partners LP is a limited partnership company focused on owning and operating high specification and versatile LNG carriers that are employed on multi-year contracts with international energy companies, providing the benefits of stable cash flows and high utilization rates. The company defines charters of two years or more as multi-year charters. Its current LNG Carrier fleet is optimized for trading flexibility. In addition to conventional trade, part of LNG Carrier fleet is assigned with Ice Class 1A FS notation and are winterized which enables trade in subzero and ice bound conditions.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.